跳至主要内容
临床试验/NL-OMON50453
NL-OMON50453招募中不适用

Randomized comparison of FemORal drug-Eluting balloons and Stents (FOREST TRIAL) - A randomized controlled trial comparing drug-eluting balloons and drug-eluting stents in the treatment of femoropopliteal arterial occlusive disease - FOREST trial

Stichting DEAll, wetenschappelijke stichting ter bevordering van vasculair wetenschappelijk onderzoek0 个研究点目标入组 254 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
254

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 years
  • Patients must be willing to sign an informed consent form
  • Rutherford-Baker class 2-6
  • At least 1 symptomatic de novo atherosclerotic lesion in the superficial
  • femoral artery and/or popliteal artery, section P1
  • There will be no maximum lesion length
  • Diameter of reference vessel between 4 to 7 mm
  • The lesion should be a stenosis of at least 50% or an occlusion assessed by
  • CT-angiography or MR-angiography or assessed by duplex ultrasound (DUS, peak
  • systolic velocity ratio (PVR) of >2.5)
  • At least 1 patent tibial runoff vessel
  • Successful passage with guide wire

排除标准

  • Life expectancy <= 1 year
  • Restenotic lesions
  • Acute femoro-popliteal occlusion
  • Recurrent stenosis or occlusion
  • Aspirin, Clopidogrel, Heparin or Paclitaxel allergy

研究者

发起方
Stichting DEAll, wetenschappelijke stichting ter bevordering van vasculair wetenschappelijk onderzoek

相似试验